Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cervical Cancer Recurrent or Persistent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00276796
What this trial is testing

Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 66
Testing effectiveness (Phase 2)Study completedNCT00041093
What this trial is testing

Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical Squamous Cell Carcinoma, Not Otherwise SpecifiedRecurrent Cervical Carcinoma
Gynecologic Oncology Group 27
Large-scale testing (Phase 3)Study completedNCT02083211
What this trial is testing

Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma

Who this might be right for
Cervical Cancer Recurrent or PersistentPalliative TreatmentMonoclonal Antibody in Cervical Cancer Treatment
National Institute of Cancerología 168
Early research (Phase 1)Study completedNCT00004062
What this trial is testing

Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Lucille P. Markey Cancer Center at University of Kentucky
Testing effectiveness (Phase 2)Study completedNCT00039442
What this trial is testing

Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma
Gynecologic Oncology Group 21
Not applicableUnknownNCT04171505
What this trial is testing

Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN.

Who this might be right for
Cervix, DysplasiaHPV InfectionHPV Vaccine+1 more
Hospital San Carlos, Madrid 508
Testing effectiveness (Phase 2)Ended earlyNCT03367871
What this trial is testing

Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
University of Miami 17
Large-scale testing (Phase 3)Looking for participantsNCT06459687
What this trial is testing

Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Lee's Pharmaceutical Limited 440
Large-scale testing (Phase 3)Active Not RecruitingNCT04982237
What this trial is testing

AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Akeso 445
Testing effectiveness (Phase 2)UnknownNCT03912402
What this trial is testing

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)

Who this might be right for
Cervical CancerCervical Cancer MetastaticCervical Cancer Recurrent
Biocad 49
Early research (Phase 1)UnknownNCT05475847
What this trial is testing

Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Fudan University 20
Testing effectiveness (Phase 2)Study completedNCT00101192
What this trial is testing

Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 76
Large-scale testing (Phase 3)Looking for participantsNCT07216703
What this trial is testing

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

Who this might be right for
Cervical Cancer
Merck Sharp & Dohme LLC 1,023
Testing effectiveness (Phase 2)Study completedNCT01267253
What this trial is testing

Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+2 more
Gynecologic Oncology Group 31
Testing effectiveness (Phase 2)Study completedNCT00026260
What this trial is testing

SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT01652794
What this trial is testing

Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer

Who this might be right for
Leydig Cell TumorOvarian SarcomaOvarian Stromal Cancer+10 more
Case Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT01194609
What this trial is testing

A Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasms
Korea Cancer Center Hospital 2
Testing effectiveness (Phase 2)WithdrawnNCT00095641
What this trial is testing

S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer

Who this might be right for
Recurrent Squamous Cell Carcinoma of the Lip and Oral CavityRecurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityRecurrent Squamous Cell Carcinoma of the Hypopharynx+2 more
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Study completedNCT00025233
What this trial is testing

Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix

Who this might be right for
Cervical Squamous Cell CarcinomaRecurrent Cervical Cancer
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Ended earlyNCT04651127
What this trial is testing

Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer

Who this might be right for
Cervical CancerCervix CancerCervix Neoplasm
Sun Yat-sen University 5
Next Page